Motzer, Robert J. : rechercher sur Z-Library

Le plus grand référentiel d'articles scientifiques au monde. 70,000,000+ d'articles gratuitement.

Don't use scam websites

Livres
Articles (329)
Les plus populaires
Liste
- Liste
- Tableau

1

Kidney Cancer

Motzer, Robert J., Agarwal, Neeraj, Beard, Clair, Bolger, Graeme B., Boston, Barry, Carducci, Michael A., Choueiri, Toni K., Figlin, Robert A., Fishman, Mayer, Hancock, Steven L., Hudes, Gary R., Jona

Journal:

Journal of the National Comprehensive Cancer Network

Année:

2009

Langue:

english

Fichier:

PDF, 504 KB

english, 2009

2

Axitinib versus sorafenib as second-line treatment for advanced renal cell carcinoma: overall survival analysis and updated results from a randomised phase 3 trial

Motzer, Robert J, Escudier, Bernard, Tomczak, Piotr, Hutson, Thomas E, Michaelson, M Dror, Negrier, Sylvie, Oudard, Stephane, Gore, Martin E, Tarazi, Jamal, Hariharan, Subramanian, Chen, Connie, Rosbr

Journal:

The Lancet Oncology

Année:

2013

Langue:

english

Fichier:

PDF, 316 KB

english, 2013

3

Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma

Motzer, Robert J., Penkov, Konstantin, Haanen, John, Rini, Brian, Albiges, Laurence, Campbell, Matthew T., Venugopal, Balaji, Kollmannsberger, Christian, Negrier, Sylvie, Uemura, Motohide, Lee, Jae L.

Journal:

New England Journal of Medicine

Année:

2019

Langue:

english

Fichier:

PDF, 333 KB

english, 2019

4

Using the Rasch Model to Validate and Enhance the Interpretation of the Functional Assessment of Cancer Therapy–Kidney Symptom Index—Disease-Related Symptoms Scale

Xuemei Luo, Joseph C. Cappelleri, David Cella, Jim Z. Li, Claudie Charbonneau, Sindy T. Kim, Isan Chen, Robert J. Motzer

Journal:

Value in Health

Année:

2009

Langue:

english

Fichier:

PDF, 140 KB

english, 2009

5

Axitinib treatment in patients with cytokine-refractory metastatic renal-cell cancer: a phase II study

Olivier Rixe, Ronald M Bukowski, M Dror Michaelson, George Wilding, Gary R Hudes, Oliver Bolte, Robert J Motzer, Paul Bycott, Katherine F Liau, James Freddo, Peter C Trask, Sinil Kim, Brian I Rini

Journal:

The Lancet Oncology

Année:

2007

Langue:

english

Fichier:

PDF, 143 KB

english, 2007

6

TERATOMA WITH MALIGNANT TRANSFORMATION: DIVERSE MALIGNANT HISTOLOGIES ARISING IN MEN WITH GERM CELL TUMORS

Motzer, Robert J., Amsterdam, Alison, Prieto, Victor, Sheinfeld, Joel, Murty, V.V.V.S., Mazumdar, Madhu, Bosl, George J., Chaganti, R.S.K., Reuter, Victor E.

Journal:

The Journal of Urology

Année:

1998

Langue:

english

Fichier:

PDF, 1.35 MB

english, 1998

7

A POSTOPERATIVE PROGNOSTIC NOMOGRAM FOR RENAL CELL CARCINOMA

KATTAN, MICHAEL W., REUTER, VICTOR, MOTZER, ROBERT J., KATZ, JARED, RUSSO, PAUL

Journal:

The Journal of Urology

Année:

2001

Langue:

english

Fichier:

PDF, 81 KB

english, 2001

8

Abdominal Pain Impacts Quality of Life in Women with Irritable Bowel Syndrome

Cain, Kevin C., Headstrom, Peggy, Jarrett, Monica E., Motzer, Sandra A., Park, Hyojung, Burr, Robert L., Surawicz, Christine M., Heitkemper, Margaret M.

Journal:

American Journal of Gastroenterology

Année:

2006

Langue:

english

Fichier:

PDF, 240 KB

english, 2006

9

Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma

Motzer, Robert J., Escudier, Bernard, McDermott, David F., George, Saby, Hammers, Hans J., Srinivas, Sandhya, Tykodi, Scott S., Sosman, Jeffrey A., Procopio, Giuseppe, Plimack, Elizabeth R., Castellan

Journal:

New England Journal of Medicine

Année:

2015

Langue:

english

Fichier:

PDF, 551 KB

english, 2015

10

Intra- and Interobserver Variability in CT Measurements in Oncology

McErlean, Aoife, Panicek, David M., Zabor, Emily C., Moskowitz, Chaya S., Bitar, Richard, Motzer, Robert J., Hricak, Hedvig, Ginsberg, Michelle S.

Journal:

Année:

2013

Langue:

english

Fichier:

PDF, 844 KB

english, 2013

11

Lenvatinib, everolimus, and the combination in patients with metastatic renal cell carcinoma: a randomised, phase 2, open-label, multicentre trial

Motzer, Robert J, Hutson, Thomas E, Glen, Hilary, Michaelson, M Dror, Molina, Ana, Eisen, Timothy, Jassem, Jacek, Zolnierek, Jakub, Maroto, Jose Pablo, Mellado, Begoña, Melichar, Bohuslav, Tomasek, Ji

Journal:

The Lancet Oncology

Année:

2015

Langue:

english

Fichier:

PDF, 381 KB

english, 2015

12

Increased Symptoms in Female IBS Patients With Dysmenorrhea and PMS

Altman, Gaylene, Cain, Kevin C., Motzer, Sandra, Jarrett, Monica, Burr, Robert, Heitkemper, Margaret

Journal:

Gastroenterology Nursing

Année:

2006

Langue:

english

Fichier:

PDF, 1.44 MB

english, 2006

13

Immune Checkpoint Therapy in Renal Cell Carcinoma

Lee, Chung-Han, Motzer, Robert J.

Journal:

The Cancer Journal

Année:

2016

Langue:

english

Fichier:

PDF, 102 KB

english, 2016

14

Nivolumab versus everolimus in advanced renal cell carcinoma: Japanese subgroup analysis from the CheckMate 025 study

Tomita, Yoshihiko, Fukasawa, Satoshi, Shinohara, Nobuo, Kitamura, Hiroshi, Oya, Mototsugu, Eto, Masatoshi, Tanabe, Kazunari, Kimura, Go, Yonese, Junji, Yao, Masahiro, Motzer, Robert J., Uemura, Hirots

Journal:

Japanese Journal of Clinical Oncology

Année:

2017

Langue:

english

Fichier:

PDF, 517 KB

english, 2017

15

Combination therapy for advanced and metastatic kidney cancer

Lee, Chung-Han, Motzer, Robert J.

Journal:

Nature Reviews Urology (formerly Nature Clinical Practice Urology)

Année:

2018

Langue:

english

Fichier:

PDF, 548 KB

english, 2018

16

Author Correction: Towards individualized therapy for metastatic renal cell carcinoma

Kotecha, Ritesh R., Motzer, Robert J., Voss, Martin H.

Journal:

Nature Reviews Clinical Oncology (formerly Nature Clinical Practice Oncology)

Année:

2019

Fichier:

PDF, 148 KB

2019

17

Efficacy of Nivolumab plus Ipilimumab According to Number of IMDC Risk Factors in CheckMate 214

Escudier, Bernard, Motzer, Robert J., Tannir, Nizar M., Porta, Camillo, Tomita, Yoshihiko, Maurer, Matthew A., McHenry, M. Brent, Rini, Brian I.

Journal:

European Urology

Année:

2019

Langue:

english

Fichier:

PDF, 993 KB

english, 2019

18

Phase IB/II Trial of Lenvatinib Plus Pembrolizumab in Patients With Advanced Renal Cell Carcinoma, Endometrial Cancer, and Other Selected Advanced Solid Tumors

Taylor, Matthew H., Lee, Chung-Han, Makker, Vicky, Rasco, Drew, Dutcus, Corina E., Wu, Jane, Stepan, Daniel E., Shumaker, Robert C., Motzer, Robert J.

Journal:

Journal of Clinical Oncology

Année:

2020

Langue:

english

Fichier:

PDF, 697 KB

english, 2020

19

Patient-reported outcomes in a phase 2 study comparing atezolizumab alone or with bevacizumab vs sunitinib in previously untreated metastatic renal cell carcinoma

Pal, Sumanta K., McDermott, David F., Atkins, Michael B., Escudier, Bernard, Rini, Brian I., Motzer, Robert J., Fong, Lawrence, Joseph, Richard W., Oudard, Stephane, Ravaud, Alain, Bracarda, Sergio, S

Journal:

BJU International

Année:

2020

Fichier:

PDF, 10.34 MB

2020

20

Systemic therapy for advanced clear cell renal cell carcinoma after discontinuation of immune-oncology and VEGF targeted therapy combinations

Ged, Yasser, Gupta, Ruby, Duzgol, Cihan, Knezevic, Andrea, Shapnik, Natalie, Kotecha, Ritesh, Voss, Martin H., Feldman, Darren R., Akin, Oguz, Patil, Sujata, Motzer, Robert J., Rini, Brian I., Lee, Ch

Journal:

Année:

2020

Fichier:

PDF, 826 KB

2020

21

Carboplatin, etoposide, and bleomycin for patients with poor-risk germ cell tumors

Robert J. Motzer, Karen Cooper, Nancy L. Geller, David G. Pfister, Shiow-Yun Lin, Dean Bajorin, Howard I. Scher, Harry Herr, William Fair, Michael Morse, Pramod Sogani, Willet Whitmore, George J. Bosl

Journal:

Année:

1990

Langue:

english

Fichier:

PDF, 536 KB

english, 1990

22

The effect of a 7-day delay in chemotherapy cycles on complete response and event-free survival in good-risk disseminated germ cell tumor patients

Robert J. Motzer, Nancy L. Geller, George J. Bosl

Journal:

Année:

1990

Langue:

english

Fichier:

PDF, 429 KB

english, 1990

23

The role of ifosfamide plus cisplatin-based chemotherapy as salvage therapy for patients with refractory germ cell tumors

Robert J. Motzer, Karen Cooper, Nancy L. Geller, Dean F. Bajorin, Ethan Dmitrovsky, Harry Herr, Michael Morse, William Fair, Pramod Sogani, Paul Russo, George J. Bosl

Journal:

Année:

1990

Langue:

english

Fichier:

PDF, 537 KB

english, 1990

24

Salvage chemotherapy for patients with germ cell tumors. The memorial sloan-kettering cancer center experience (1979–1989)

Robert J. Motzer, Nancy L. Geller, Claire C.-Y. Tan, Harry Herr, Michael Morse, William Fair, Joel Sheinfeld, Pramod Sogani, Paul Russo, George J. Bosl

Journal:

Année:

1991

Langue:

english

Fichier:

PDF, 542 KB

english, 1991

25

High-dose chemotherapy and autologous bone marrow rescue for patients with refractory germ cell tumors. Early intervention is better tolerated

Robert J. Motzer, Subhash C. Gulati, John P. Crown, Steven Weisen, Maryanne Doherty, Harry Herr, William Fair, Joel Sheinfeld, Pramod Sogani, Paul Russo, George J. Bosl

Journal:

Année:

1992

Langue:

english

Fichier:

PDF, 682 KB

english, 1992

26

Surgical resection of solitary metastases after chemotherapy in patients with nonseminomatous germ cell tumors and elevated serum tumor markers

David P. Wood Jr., Hary W. Herr, Robert J. Motzer, Victor Reuter, Pramod C. Sogani, Michael J. Morse, George J. Bosl

Journal:

Année:

1992

Langue:

english

Fichier:

PDF, 400 KB

english, 1992

27

Beneficial impact of peripheral blood progenitor cells in patients with metastatic breast cancer treated with high-dose chemotherapy plus granulocyte-macrophage colony-stimulating factor a randomized trial

Alan Kritz, John P. Crown, Robert J. Motzer, Lilian M. Reich, Glenn Heller, Michael P. Moore, Nicola Hamilton, T. J. Yao, Robert T. Heelan, Jeffrey G. Schneider, Malcolm A. S. Moore, Beryl McCormick,

Journal:

Année:

1993

Langue:

english

Fichier:

PDF, 672 KB

english, 1993

28

Optimal treatment for advanced seminoma?

Robert J. Motzer

Journal:

Année:

1993

Langue:

english

Fichier:

PDF, 173 KB

english, 1993

29

Suramin for germ cell tumors. In vitro growth inhibition and results of a phase II trial

Robert J. Motzer, Ethan Dmitrovsky, Wilson H. Miller Jr., William P. Tong, Dean F. Bajorin, Howard I. Scher, George J. Bosl

Journal:

Année:

1993

Langue:

english

Fichier:

PDF, 523 KB

english, 1993

30

Hormonal ablation as effective therapy for carcinomatous meningitis from prostatic carcinoma

Peter J. Mencel, Lisa M. Deangelis, Robert J. Motzer

Journal:

Année:

1994

Langue:

english

Fichier:

PDF, 254 KB

english, 1994

31

Serum tumor marker decline is an early predictor of treatment outcome in germ cell tumor patients treated with cisplatin and ifosfamide salvage chemotherapy

Barbara A. Murphy, Robert J. Motzer, Madhu Mazumdar, Vaia Vlamis, Jerome Nisselbaum, Dean Bajorin, George J. Bosl

Journal:

Année:

1994

Langue:

english

Fichier:

PDF, 655 KB

english, 1994

32

Platinum-DNA adducts assayed in leukocytes of patients with germ cell tumors measured by atomic absorbance spectrometry and enzyme-linked immunosorbent assay

Robert J. Motzer, Eddie Reed, Frederica Perera, Deliang Tang, Hanadi Shamkhani, Miriam C. Poirier, Wei-Yann Tsai, Ricardo J. Parker, George J. Bosl

Journal:

Année:

1994

Langue:

english

Fichier:

PDF, 837 KB

english, 1994

33

all-trans retinoic acid for treating germ cell tumors. In vitro activity and results of a phase II trial

Mark M. Moasser, Robert J. Motzer, Kei-Siong Khoo, Peter Lyn, Barbara A. Murphy, George J. Bosl, Ethan Dmitrovsky

Journal:

Année:

1995

Langue:

english

Fichier:

PDF, 677 KB

english, 1995

34

Phase iii randomized trial of interleukin-2 with or without lymphokine-activated killer cells in the treatment of patients with advanced renal cell carcinoma

Teresa Murray Law, Robert J. Motzer, Madhu Mazumdar, Kenneth W. Sell, Philip Walther, Michael O'Connell, Amanullah Khan, Vaia Vlamis, Nicholas J. Vogelzang, Dean F. Bajorin

Journal:

Année:

1995

Langue:

english

Fichier:

PDF, 723 KB

english, 1995

35

Response assessment classification in patients with advanced renal cell carcinoma treated on clinical trials : Effect of measurement criteria and other parameters

Lawrence H. Schwartz, Madhu Mazumdar, Liang Wang, Alex Smith, Stephanie Marion, David M. Panicek, Robert J. Motzer

Journal:

Année:

2003

Langue:

english

Fichier:

PDF, 200 KB

english, 2003

36

Thrombocytosis as a prognostic factor for survival in patients with metastatic renal cell carcinoma

Revathi Suppiah, Philip E. Shaheen, Paul Elson, Seema A. Misbah, Laura Wood, Robert J. Motzer, Slyvie Negrier, Steven W. Andresen, Ronald M. Bukowski

Journal:

Année:

2006

Langue:

english

Fichier:

PDF, 129 KB

english, 2006

37

Treatment outcome for metastatic papillary renal cell carcinoma patients

Ellen A. Ronnen, G. Varuni Kondagunta, Nicole Ishill, Lesley Spodek, Paul Russo, Victor Reuter, Jennifer Bacik, Robert J. Motzer

Journal:

Année:

2006

Langue:

english

Fichier:

PDF, 91 KB

english, 2006

38

The indication for postchemotherapy lymph node dissection in clinical stage IS nonseminomatous germ cell tumor

Atreya Dash, Brett S. Carver, Jason Stasi, Dean F. Bajorin, Robert J. Motzer, George J. Bosl, Joel Sheinfeld

Journal:

Année:

2008

Langue:

english

Fichier:

PDF, 111 KB

english, 2008

39

Prognostic nomogram for sunitinib in patients with metastatic renal cell carcinoma

Robert J. Motzer, Ronald M. Bukowski, Robert A. Figlin, Thomas E. Hutson, M. Dror Michaelson, Sindy T. Kim, Charles M. Baum, Michael W. Kattan

Journal:

Année:

2008

Langue:

english

Fichier:

PDF, 115 KB

english, 2008

40

Stage migration and increasing proportion of favorable-prognosis metastatic renal cell carcinoma patients : Implications for clinical trial design and interpretation

Sujata Patil, Nicole Ishill, John Deluca, Robert J. Motzer

Journal:

Année:

2010

Langue:

english

Fichier:

PDF, 195 KB

english, 2010

41

Phase 3 trial of everolimus for metastatic renal cell carcinoma : Final results and analysis of prognostic factors

Robert J. Motzer, Bernard Escudier, Stephane Oudard, Thomas E. Hutson, Camillo Porta, Sergio Bracarda, Viktor Grünwald, John A. Thompson, Robert A. Figlin, Norbert Hollaender, Andrea Kay, Alain Ravaud

Journal:

Année:

2010

Langue:

english

Fichier:

PDF, 426 KB

english, 2010

42

Evaluation of lymph node counts in primary retroperitoneal lymph node dissection

R. Houston Thompson, Brett S. Carver, George J. Bosl, Dean Bajorin, Robert Motzer, Darren Feldman, Victor E. Reuter, Joel Sheinfeld

Journal:

Année:

2010

Langue:

english

Fichier:

PDF, 183 KB

english, 2010

43

Progression-free and overall survival in patients with relapsed/refractory germ cell tumors treated with single-agent chemotherapy: Endpoints for clinical trial design

Darren R. Feldman, Sujata Patil, Michael J. Trinos, Maryann Carousso, Michelle S. Ginsberg, Joel Sheinfeld, Dean F. Bajorin, George J. Bosl, Robert J. Motzer

Journal:

Année:

2012

Langue:

english

Fichier:

PDF, 817 KB

english, 2012

44

Total lymphoid irradiation and high-dose chemotherapy followed by autologous bone marrow transplantation for relapsed or refractory Hodgkin's disease: 7-year experience

Joachim Yahalom, Subhash Gulati, Maria Toia, Robert Motzer, John Crown, Peter Maslak, Zvi Fuks

Journal:

International Journal of Radiation Oncology*Biology*Physics

Année:

1992

Langue:

english

Fichier:

PDF, 215 KB

english, 1992

45

Renal cell carcinoma

Robert J. Motzer, David M. Nanus, Paul Russo, William J. Berg

Journal:

Current Problems in Cancer

Année:

1997

Langue:

english

Fichier:

PDF, 2.68 MB

english, 1997

46

Prognostic factors and clinical trials of new agents in patients with metastatic renal cell carcinoma

Robert J. Motzer

Journal:

Critical Reviews in Oncology/Hematology

Année:

2003

Langue:

english

Fichier:

PDF, 218 KB

english, 2003

47

Phase II trial of Didemnin B in patients with advanced renal cell carcinoma

Robert Motzer, Howard Scher, Dean Bajorin, Cora Sternberg, George J. Bosl

Journal:

Investigational New Drugs

Année:

1990

Langue:

english

Fichier:

PDF, 115 KB

english, 1990

48

Carboplatin-based chemotherapy with pharmacokinetic analysis for patients with hemodialysis-dependent renal insufficiency

Robert J. Motzer, Donna Niedzwiecki, Marion Isaacs, Celia Menendez-Botet, William P. Tong, Carlos Flombaum, Howard I. Scher, George J. Bosl

Journal:

Cancer Chemotherapy and Pharmacology

Année:

1990

Langue:

english

Fichier:

PDF, 568 KB

english, 1990

49

Phase II trial of topotecan in patients with cisplatin-refractory germ cell tumors

Heidi Sonya Puc, Dean F. Bajorin, George J. Bosl, Alison Amsterdam, Robert J. Motzer

Journal:

Investigational New Drugs

Année:

1995

Langue:

english

Fichier:

PDF, 171 KB

english, 1995

50

Phase II trial of liposomal encapsulated doxorubicin in patients with advanced renal cell carcinoma

Teresa Murray Law, Peter Mencel, Robert J. Motzer

Journal:

Investigational New Drugs

Année:

1994

Langue:

english

Fichier:

PDF, 158 KB

english, 1994